Iraq Active Pharmaceutical Ingredients Market Size & Outlook

The active pharmaceutical ingredients market in Iraq is expected to reach a projected revenue of US$ 128.5 million by 2030. A compound annual growth rate of 7% is expected of Iraq active pharmaceutical ingredients market from 2024 to 2030.
Revenue, 2023 (US$M)
$80.0
Forecast, 2030 (US$M)
$128.5
CAGR, 2024 - 2030
7%
Report Coverage
Iraq

Iraq active pharmaceutical ingredients market, 2018-2030 (US$M)

Iraq
Unlock Premium

Related Markets

Iraq active pharmaceutical ingredients market highlights

  • The Iraq active pharmaceutical ingredients market generated a revenue of USD 80.0 million in 2023 and is expected to reach USD 128.5 million by 2030.
  • The Iraq market is expected to grow at a CAGR of 7% from 2024 to 2030.
  • In terms of segment, synthetic was the largest revenue generating type of synthesis in 2023.
  • Synthetic is the most lucrative type of synthesis segment registering the fastest growth during the forecast period.


Active pharmaceutical ingredients market data book summary

Market revenue in 2023USD 80.0 million
Market revenue in 2030USD 128.5 million
Growth rate7% (CAGR from 2023 to 2030)
Largest segmentSynthetic
Fastest growing segmentSynthetic
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSynthetic, Biotech
Key market players worldwideDr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi


Other key industry trends

  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa active pharmaceutical ingredients market is projected to lead the regional market in terms of revenue in 2030.
  • Kuwait is the fastest growing regional market in Middle East & Africa and is projected to reach USD 126.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Active Pharmaceutical Ingredients Market Scope

Active pharmaceutical ingredients market segmentation & scope
Synthetic
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Hormones
Cytokines
Therapeutic Enzymes
Blood Factors
Captive APIs
Biotech Merchant APIs
Synthetic Merchant APIs
Generic APIs
Innovative APIs
Cardiovascular Diseases
Oncology
CNS and Neurology
Orthopedic
Endocrinology
Pulmonology
Gastroenterology
Nephrology
Ophthalmology
Others
Prescription
OTC

Active Pharmaceutical Ingredients Market Companies

Name Profile # Employees HQ Website

Iraq active pharmaceutical ingredients market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.


Synthetic was the largest segment with a revenue share of 70.75% in 2023. Horizon Databook has segmented the Iraq active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Iraq active pharmaceutical ingredients market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Iraq active pharmaceutical ingredients market databook

  • Our clientele includes a mix of active pharmaceutical ingredients market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Iraq active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Iraq active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Iraq active pharmaceutical ingredients market size, by type of synthesis, 2018-2030 (US$M)

Iraq Active Pharmaceutical Ingredients Market Outlook Share, 2023 & 2030 (US$M)

Iraq active pharmaceutical ingredients market size, by type of synthesis, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more